EYE CANCER

Authors

  • Strahil Gazepov University “Goce Delcev” Shtip N.Macedonia
  • Funda Alicov University “Goce Delcev” Shtip N.macedonia

Keywords:

Eye cancer, risk factors, diagnostic methods

Abstract

The most prevalent kind of adult eye cancer is uveal melanoma, which mainly affects people aged 20 to 50. A history of sunburn, light-colored eyes, pale skin, and high sensitivity to sunlight are associated with a higher risk of this illness. The majority of patients are detected at the metastatic stage since its symptoms are frequently deceptive. A thorough and meticulous eye examination is necessary for the diagnosis procedure. Radiation therapy, surgery, laser therapy, or thermo therapy are often the available treatment choices when the condition has been conclusively identified. The patient’s general health and the disaesa’s stage are taken into consideration while selecting these treatment options. In general, eye cancer is an uncommon condition that comes in a variety of forms. The most prevalent kind of eye cancer is uveal melanoma,which is followed by retinoblastoma and conjunctival carcinoma. Eye cancer may behave differently biologically than tumors in other body regions. Intraocular malignancies like uveal melanoma are frequently treated with organ-preserving techniques including radiation, laser treatment, and cryotherapy. These therapies seek to inhibit tumor development while preserving as much of the eye’s structure and visual function as feasible. When the tumor is too advanced to be managed with these techniques, enucleation-the surgical removal of the eye-may be required to stop the cancer from spreading. Uveal melanoma symptoms can vary greatly, such as a black patch on the iris, impaired vision, or loss of visual field. Nevertheless, the illness frequently doesn’t show any symptoms until it has progressed to a more severe level. This frequently postpones diagnosis, which raises the likelihood of metastases. The most frequent source of metastasis for cancer that has progressed outside of the eye is the liver, which considerably lowers the prognosis. Although the main goal of treatment is to contain the tumor inside the eye, it is equally important to keep a look out for metastases. Frequent imaging tests, such CT, MRI, or ultrasound scans, can be used to determine the disease’s severity and guarantee early identification of any spread. With few systemic therapy options, the prognosis for metastatic uveal melanoma is still dismal, despite advancements in targeted therapeutic techniques.

References

Carvajal, R. D., Piperno-Neumann, S., Kapiteijn, E., & Nathan, P. (2017). “Uveal melanoma: Arare disease in need of better therapies.” The Lancet Oncology, 18(3), e196-e207.

Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, & Hurwitz R. (2007); Retinoblastoma: review of current management. Oncologist. 12:1237-46.

Damato, B., & Coupland, S. E. (2012). “Ocular melanoma.” Saudi Journal of Ophthalmology, 26(2), 137-144.

He W., Ting L.,Yongjie H., Wuyi M., Jinguang D., Yinxia L., & Yuan Y. (2022) et al. “ A review: The detection of cancer cells in histopathology based on machine vision.” Computers in Biology and Medicine 146 105636.

Jager, M. J., Shields, C. L., Cebulla, C. M., et al. (2020). “Uveal melanoma.” Nature Reviews Disaeas Primers, 6(1), 24.

Jenkinson H.(2022). Retinoblastoma: diagnosis and management - the UK perspective. Arch Dis Child.;100:1070-5.

Kaliki, S., & Shields, C. L. (2017). “Uveal melanoma: relatively rare but deadly cancer,” Eye, 31(2), 241-257.

Kivela TT, & Hadjistilianou T. (2017) Neonatal retinoblastoma. Asia Pac J Oncol Nurs.;4:197-204.

Mayer Ch., Efrat O., Danielle E. F., Yossef M., Rina Y., Inbal G., Ido H., Jonathan Z., Paz-Yaacov N., & Iris B.. (2022): “ Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms.” Modern Pathology 35, no. 121882-1887.

Millen,G.C., Lawford, A., & Duncan, C. (2024). et al. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. Br J Cancer 131,491-497

Nathan, P. (2015)e t al. Uveal Melanoma Guideline Development Working Group. Uveal Melanoma UK National Guidelines. Eur J Cancer. Nov;51(16):2404-12. doi.10.1016

Singh, A. D., Turell, M. E., & Topham, A.K. (2011). “Uveal melanoma: trends in incidence, treatment, and survival.” OPhthalmology, 118(9), 1881-1885.

Qaddoumi, I., Bass, J.K., Wu, J., Billups, C.A., Wozanika, A.W., Merchant (2012) , et al. Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol.;30:1034-41.

Downloads

Published

2025-02-13

How to Cite

Gazepov, S., & Alicov, F. (2025). EYE CANCER. KNOWLEDGE - International Journal , 68(4), 487–490. Retrieved from https://ojs.ikm.mk/index.php/kij/article/view/7166

Most read articles by the same author(s)

<< < 2 3 4 5 6 7